Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
Sung Hee Hwang, Aaron T Wecksler, Guodong Zhang, Christophe Morisseau, Long V Nguyen, Samuel H Fu, Bruce D Hammock
文献索引：Bioorg. Med. Chem. Lett. 23(13) , 3732-7, (2013)
全文：HTML全文
摘要
To reduce the pro-angiogenic effects of sEH inhibition, a structure-activity relationship (SAR) study was performed by incorporating structural features of the anti-angiogenic multi-kinase inhibitor sorafenib into soluble epoxide hydrolase (sEH) inhibitors. The structural modifications of this series of molecules enabled the altering of selectivity towards the pro-angiogenic kinases C-RAF and vascular endothelial growth factor receptor-2 (VEGFR-2), while retaining their sEH inhibition. As a result, sEH inhibitors with greater potency against C-RAF and VEGFR-2 were obtained. Compound 4 (t-CUPM) possesses inhibition potency higher than sorafenib towards sEH but similar against C-RAF and VEGFR-2. Compound 7 (t-CUCB) selectively inhibits sEH, while inhibiting HUVEC cell proliferation, a potential anti-angiogenic property, without liver cancer cell cytotoxicity. The data presented suggest a potential rational approach to control the angiogenic responses stemming from sEH inhibition.Copyright © 2013 Elsevier Ltd. All rights reserved.
相关化合物
相关文献：
2011-12-15
[Bioorg. Med. Chem. 19(24) , 7603-1, (2011)]
2013-03-01
[Cancer Biol. Ther. 14(3) , 278-85, (2013)]
A highly efficient methodology for 5-methyl-3-aryl-2-thiooxazolidin-4-ones using lithium perchlorate in DIPEA mediated synthesis. Khatik GL, et al.
[J. Heterocycl. Chem. 47(3) , 734, (2010)]
Extraction and determination of the Mitins sulcofuron and flucofuron from environmental river water. áM Hancock P.
[Analyst 123(8) , 1669-74, (1998)]